{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:09Z","timestamp":1791409869379,"version":"4.3.3"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110413","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:21:45Z","timestamp":1787095305000},"page":"110413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chimeric pyrrolodiketo-pyrrolidine-phthalazine \u2013 triazole derivatives: synthesis, structure, stereochemistry, and anticancer activity"],"prefix":"10.1016","volume":"181","author":[{"given":"Marius","family":"Savu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilichia","family":"Antoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Elena","family":"Carp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Shova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mariana","family":"Uritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruna Maria","family":"Furtuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Al-Matarneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitica","family":"Ciorpac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina","family":"Amariucai-Mantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionel I.","family":"Mangalagiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110413_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.glt.2024.01.001","article-title":"Cancer as a global health crisis with deep evolutionary roots","volume":"6","author":"Rainer","year":"2024","journal-title":"Glob. Transit."},{"key":"10.1016\/j.bioorg.2026.110413_bb0010","article-title":"Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019","volume":"2","author":"Zhao","year":"2023","journal-title":"BMJ Oncol."},{"key":"10.1016\/j.bioorg.2026.110413_bb0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome - biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110413_bb0020","author":"WHO"},{"key":"10.1016\/j.bioorg.2026.110413_bb0030","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110413_bb0035","first-page":"229","article-title":"Global Cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110413_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2025.09.041","article-title":"Designing nucleic acid-based therapeutics for cancer treatment: updates on the state of the art","volume":"34","author":"Peng","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2026.110413_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-024-00094-4","article-title":"The changing landscape of cancer cell therapies: clinical trials and real-world data","volume":"23","author":"Saez-Iba\u00f1ez","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110413_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bioorg.2026.110413_bb0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2018.01.001","article-title":"New tools for old drugs: functional genetic screens to optimize current chemotherapy","volume":"36","author":"Gerhards","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2026.110413_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mpmed.2015.10.014","article-title":"Hormonal therapy for cancer","volume":"44","author":"Abraham","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.bioorg.2026.110413_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110413_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drup.2016.07.001","article-title":"Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics","volume":"28","author":"Wijdeven","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2026.110413_bb0075","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2011.40.3824","article-title":"The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs","volume":"30","author":"Niraula","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110413_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","article-title":"Circumventing cancer drug resistance in the era of personalized medicine","volume":"2","author":"Garraway","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.110413_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-026-11489-3","article-title":"Phthalazine scaffolds in medicinal chemistry: a review of their synthesis, versatility, and pharmacological significance","author":"Lakkad","year":"2026","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110413_bb0090","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/j.bmc.2019.07.050","article-title":"Synthesis and biological activity of structurally diverse phthalazine derivatives: a systematic review","volume":"27","author":"Sangshetti","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0100","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110413_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70262","article-title":"Pyrrolidine derivatives in modern drug discovery: emerging structure activity relationships and dual antidiabetic-anticancer potential","volume":"87","author":"Bhat","year":"2026","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110413_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114954","article-title":"Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: recent developments and future prospects (a review)","volume":"246","author":"Bhat","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104425","article-title":"Synthetic and medicinal chemistry of phthalazines: recent developments, opportunities and challenges","volume":"105","author":"Zaib","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/0115734064278334231211054053","article-title":"Nitrogen-fused heterocycles: empowering anticancer drug discovery","volume":"20","author":"Biswas","year":"2024","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0125","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/acs.jmedchem.8b01689","article-title":"Design and synthesis of 1,2-bis(hydroxymethyl)pyrrolo[2,1- a]phthalazine hybrids as potent anticancer agents that inhibit angiogenesis and induce DNA Interstrand cross-links","volume":"62","author":"Chang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202503325","article-title":"Synthesis, anticancer evaluation, and molecular docking of triazolylmethyl-dihydroquinazolinyl benzoate derivatives as potential PARP-1 inhibitors","volume":"23","author":"Londhe","year":"2026","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.110413_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144674","article-title":"Exploring quinazolinone linked 1,4-disustituted mono- and bis-1,2,3-triazole derivatives: a combined synthetic, anticancer, and molecular docking study","volume":"1353","author":"Londhe","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110413_bb0140","article-title":"The current landscape of 1,2,3-triazole-(fused) six-membered nitrogen-containing heteroaromatic ring hybrids with anticancer therapeutic potential","volume":"358","author":"Xu","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.110413_bb0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/00397911.2025.2601666","article-title":"Synthesis, in silico and in vitro assessment of new quinazolinone tethered triazole derivatives as anticancer agents","volume":"55","author":"Londhe","year":"2025","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110413_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140072","article-title":"Design, synthesis and molecular docking study of novel quinoline\u2013triazole molecular hybrids as anticancer agents","volume":"1321","author":"Bakale","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110413_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-57689-5","article-title":"1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies","volume":"14","author":"Belay","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110413_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144627","article-title":"Quinoline-integrated bis-triazole molecular hybrids: synthesis, in vitro, docking, and ADMET evaluation for antimalarial and antimicrobial potentials","volume":"1353","author":"Sulakhe","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110413_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402665","article-title":"Microwave-assisted synthesis of Bis-1,2,3-triazole-based benzophenones vitro antimicrobial activity, and molecular docking studies","volume":"22","author":"Dharavath","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.110413_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116235","article-title":"Design, synthesis, and molecular Modeling studies of novel 2-Quinolone-1,2,3-triazole-\u03b1-aminophosphonates hybrids as dual antiviral and antibacterial agents","volume":"268","author":"El Gadali","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114888","article-title":"1,2,3-triazole- containing hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"244","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127579","article-title":"Synthesis, biological evaluation and molecular docking study of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents","volume":"30","author":"Phatak","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110413_bb0185","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/jhet.3622","article-title":"Design, regiospecific green synthesis, chemical computational analysis, and antimicrobial evaluation of novel phthalazine heterocycles","volume":"56","author":"Rizk","year":"2019","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11164-025-05767-2","article-title":"Aqueous micellar catalysis for the efficient synthesis of chromeno-pyrazolo[1,2-b]phthalazines and indazolo[1,2-b]phthalazines, their plausible therapeutic implications and DFT investigations","volume":"52","author":"Bhosle","year":"2026","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2026.110413_bb0195","doi-asserted-by":"crossref","first-page":"10722","DOI":"10.1021\/acs.jmedchem.4c02615","article-title":"Development of novel Phthalazinone-triazole hybrids as potential antidiabetic agents targeting GLUT4 translocation in skeletal muscle","volume":"68","author":"Kushawaha","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202502778","article-title":"1,2,3-triazole-aminobenzoates: design, synthesis, in vitro antidiabetic and anti-Alzheimer activities, molecular docking, and ADME properties","volume":"10","author":"\u015euekinci Y\u0131lmaz","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110413_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500263","article-title":"Adamantane-appended 1,2,3-triazole hybrids: synthesis and \u03b1-glucosidase inhibition studies through experimental and in silico approach","volume":"20","author":"Ragshaniya","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110413_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400067","article-title":"Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti Alzheimer\u2019s agents","volume":"357","author":"Nuha","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.110413_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106750","article-title":"Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as \u03b1-glucosidase inhibitors","volume":"139","author":"Ritu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ica.2017.05.045","article-title":"Synthesis, structural and biological studies of two new Co(III) complexes with tridentate hydrazone ligand derived from the antihypertensive drug hydralazine","volume":"466","author":"Soliman","year":"2017","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110413_bb0225","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1248\/cpb.36.2669","article-title":"Studies on vasoactive heterocyclic compounds. Preparation and evaluation of the hypotensive and antiaggregating activities of phthalazinol nitrates","volume":"36","author":"Ito","year":"1988","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.bioorg.2026.110413_bb0230","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00044-017-1879-9","article-title":"Synthesis and vasorelaxant and antiplatelet activities of a new series of (4-Benzylphthalazin-1-ylamino)alcohol derivatives","volume":"26","author":"Mun\u00edn","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110413_bb0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2012.02.051","article-title":"Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives","volume":"52","author":"Awadallah","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/dmd.120.091090","article-title":"Human aldehyde oxidase 1-mediated carbazeran oxidation in chimeric TK-NOG mice transplanted with human hepatocytes","volume":"48","author":"Uehara","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2026.110413_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/joch\/9411347","article-title":"Synthesis and evaluation of molecular docking and anti-inflammatory activity of new 1,2,3-triazole derivatives","volume":"2026","author":"Aitha","year":"2026","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13065-025-01449-7","article-title":"Synthesis and anti-inflammatory activity of novel 1,2,3-triazole- derivatives from 7-Oxodehydroabietic acid","volume":"19","author":"Lv","year":"2025","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0255","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2174\/0115701808239556231121065200","article-title":"Anti-inflammatory effect of novel 2-Phenylphthalazin-2-ium bromides on LPS-induced RAW264. 7 cells and their mechanism","volume":"21","author":"Cao","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2026.110413_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871523017666180413111321","article-title":"Design, synthesis, characterization, QSAR, docking, anti-inflammatory and analgesic evaluation of some new phthalazinediones","volume":"17","author":"Sherif","year":"2018","journal-title":"Anti-Inflamm. Anti-Allergy Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0265","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bmcl.2016.02.008","article-title":"Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo [3,4-a]phthalazine-3-carboxamide derivatives","volume":"26","author":"Liu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110413_bb0270","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/acs.jmedchem.4c01122","article-title":"An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved pharmaceuticals (2013\u22122023)","volume":"67","author":"Marshall","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bioorg.2026.110413_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107723","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2025 update","volume":"216","author":"Roskoski","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110413_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113359","article-title":"[3 + n] cycloaddition reactions: a milestone approach for elaborating pyridazine of potential interest in medicinal chemistry and optoelectronics","volume":"26","author":"Amariucai-Mantu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110413_bb0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1135\/cccc20040426","article-title":"1,3-dipolar cycloaddition reactions of p-Halogenophenyl-Phthalazinium ylides to activated alkenes and alkynes","volume":"69","author":"Caprosu","year":"2004","journal-title":"Collect. Czech Chem. C."},{"key":"10.1016\/j.bioorg.2026.110413_bb0295","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1016\/0040-4020(96)00432-2","article-title":"Pyridazinium ylides. Regiochemistry","volume":"52","author":"Mangalagiu","year":"1996","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110413_bb0300","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.3390\/ijms26178368","article-title":"Functionalized indolizines as potential anticancer agents: synthetic, biological and in silico investigation","volume":"26","author":"Ciorteanu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110413_bb0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/0929867326666181220094229","article-title":"Hybrid imidazole - pyridine derivatives: computational approach to novel anticancer DNA intercalators","volume":"27","author":"Lungu","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0310","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.mehy.2010.07.051","article-title":"Considerations concerning design and mechanism of action of a new class of dual DNA intercalators","volume":"75","author":"Luca","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bioorg.2026.110413_bb0315","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/138161209787315594","article-title":"Designing multiple ligands medicinal chemistry strategies and challenges","volume":"15","author":"Morphy","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2026.110413_bb0320","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156802662205220304155829","article-title":"Recent advances in the use of multitarget therapeutics","volume":"22","author":"Rodrigues","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0325","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118069","article-title":"Current strategies in design and synthesis of antifungals hybrid and chimeric diazine derivatives","volume":"119","author":"Diaconu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0335","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11523-019-00680-2","article-title":"PARP inhibition in Cancer: an update on clinical development","volume":"14","author":"Sachdev","year":"2019","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bioorg.2026.110413_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104233","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors","volume":"103","author":"El-Helby","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0345","doi-asserted-by":"crossref","unstructured":"M.M. Khalifa, A.A. Al-Karmalawy, E.B. Elkaeed, M.S. Nafie, M.A. Tantawy, I.H. Eissa, & H.A. Mahdy. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies. J. Enzyme Inhib. Med. Chem., 37(1), 299\u2013314. Doi: https:\/\/doi.org\/10.1080\/14756366.2021.2007905.","DOI":"10.1080\/14756366.2021.2007905"},{"key":"10.1016\/j.bioorg.2026.110413_bb0350","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1039\/D4RA08134J","article-title":"Recent advances on anticancer activity of benzodiazine heterocycles through kinase inhibition","volume":"15","author":"Nafie","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110413_bb0370","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s40425-019-0725-7","article-title":"Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy","volume":"7","author":"Shi","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.110413_bb0375","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1023\/A:1006052923468","article-title":"Pre-clinical and clinical review of vorozole, a new third-generation aromatase inhibitor","volume":"49","author":"Goss","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bioorg.2026.110413_bb0380","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110413_bb0385","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nprot.2010.1","article-title":"Alkyne\u2013azide click reaction catalyzed by metallic copper under ultrasound","volume":"5","author":"Cintas","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110413_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116037","article-title":"Click chemistry-aided drug discovery: a retrospective and prospective outlook","volume":"264","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0395","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110413_bb0400","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s42004-024-01179-2","article-title":"Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning","volume":"7","author":"Daina","year":"2024","journal-title":"Comms. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0405","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","article-title":"Shaping the interaction landscape of bioactive molecules","volume":"29","author":"Gfeller","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2026.110413_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110413_bb0415","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecule","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110413_bb0420","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110413_bb0440","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110413_bb0445","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110413_bb0450","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.110413_bb0455","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.bmcl.2013.03.042","article-title":"Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach","volume":"10","author":"Sanphanya","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110413_bb0460","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-026-00984-x","article-title":"PARP-1 inhibitors in cancer therapy: design, molecular modeling, structure\u2013activity relationships, and clinical advances","volume":"12","author":"Abdullah","year":"2026","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110413_bb0425","series-title":"CrysAlis pro Software System","author":"Rigaku Oxford Diffraction","year":"2015"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110413_bb0430","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT - integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. A: Found. Crystallogr."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110413_bb0435","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:07:14Z","timestamp":1791407234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":88,"alternative-id":["S0045206826009491"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110413","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric pyrrolodiketo-pyrrolidine-phthalazine \u2013 triazole derivatives: synthesis, structure, stereochemistry, and anticancer activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110413"}}